The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Open accessAbstract
CRISPR-Cas9–based genetic screens are a powerful new tool in biology. By simply altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target different sites in the genome with relative ease, but the on-target activity and off-target effects of individual sgRNAs can vary widely. Here, we use recently devised sgRNA design rules to create human and mouse genome-wide libraries, perform positive and negative selection screens and observe that the use of these rules produced improved results. Additionally, we profile the off-target activity of thousands of sgRNAs and develop a metric to predict off-target sites. We incorporate these findings from large-scale, empirical data to improve our computational design rules and create optimized sgRNA libraries that maximize on-target activity and minimize off-target effects to enable more effective and efficient genetic screens and genome engineering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, it can identify genes related to drug resistance in cancer cells and facilitate research on overcoming this resistance [8].”
From A Review of Research on CRISPR/Cas9 Gene Editing Technology in Disease Treatment (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The CFD algorithm is derived from a CRISPR/Cas9 genetic screen experiment that assessed the off-target effects of thousands of sgRNAs (Doench et al., 2016).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Primarily, the sequence of sgRNAs is a crucial factor affecting on-target and off target efficiency.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Different sgRNAs targeting the same gene locus can have distinct outcomes”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“We used the STARS algorithm (Doench et al., 2016) to derive 38 hits, 18 of which were shared across at least two cell lines”
From Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma (2020) · cites this paper as Doench et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“In addition, although our sgRNA pool was designed in silico to minimize the probability of SpCas9 off-target activity52, the GUIDE-seq assay for sgRNA+119 revealed 11 off-target sites throughout the genome (Supplementary Figs. 11h and 4d).”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [52]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although TREM2 has been shown to bind to Aβ and facilitate its uptake80,81, the surface expression changes of other receptors involved in Aβ recognition and uptake might have counteracted the effects of increased TREM2 signaling upon INPP5D haploinsufficiency83,84.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, Aβ can bind to lipoproteins such as clusterin (ApoJ) and ApoE in the brain82–84, which facilitates its clearance by microglia via TREM281.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Research works printed but not linked: 1
- Steiger, J.H. Tests for comparing elements of a correlation matrix. Psychol. Bull. 87, 245–251 (1980). · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 1,030
CRISPR/Cas9: Development and Application in Rice Breeding
Romero, F. M., & Gatica-Arias, A. (2019) · Rice Science · doi:10.1016/j.rsci.2019.08.001 · Cited by 118
Protein expression and gene editing in monocots using foxtail mosaic virus vectors
Yu, M., Beernink, B. M., Ellison, E. E., Konečná, E., Neelakandan, A. K., Voytas, D. F., & Whitham, S. A. (2019) · Plant Direct · doi:10.1002/pld3.181 · Cited by 110
Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage
Riesenberg, S., Helmbrecht, N., Kanis, P., Maricic, T., & Pääbo, S. (2022) · Nature Communications · doi:10.1038/s41467-022-28137-7 · Cited by 109
Yan, Q., & Fong, S. S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02060 · Cited by 112
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Li, Y., Glass, Z., Huang, M., Chen, Z., & Xu, Q. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119711 · Cited by 118
Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy
Chen, L., Wang, S., Zhang, Y., Li, J., Xing, Z., Yang, J., Huang, T., & Cai, Y. (2017) · IEEE Access · doi:10.1109/access.2017.2775703 · Cited by 109
CRISPR/Cas9 library screening for drug target discovery
Kurata, M., Yamamoto, K., Moriarity, B. S., Kitagawa, M., & Largaespada, D. A. (2017) · Journal of Human Genetics · doi:10.1038/s10038-017-0376-9 · Cited by 108
New CRISPR Mutagenesis Strategies Reveal Variation in Repair Mechanisms among Fungi
Vyas, V. K., Bushkin, G. G., Bernstein, D. A., Getz, M. A., Sewastianik, M., Barrasa, M. I., Bartel, D. P., & Fink, G. R. (2018) · mSphere · doi:10.1128/msphere.00154-18 · Cited by 107
Wang, S., Zhang, Q., Tiwari, S. K., Lichinchi, G., Yau, E. H., Hui, H., Li, W., Furnari, F. B., & Rana, T. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.11.020 · Cited by 105
Liu, R., Yeh, Y.-H. J., Varabyou, A., Collora, J. A., Sherrill-Mix, S. A., Talbot, C. C., Mehta, S. S., Albrecht, K., Hao, H., Zhang, H., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz0802 · Cited by 105
Li, Y., He, Y., Peng, J., Su, Z., Li, Z., Zhang, B., Ma, J., Zhuo, M., Zou, D., Liu, X., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00134-z · Cited by 108
The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses
Jongsma, M. L. M., de Waard, A. A., Raaben, M., Zhang, T., Cabukusta, B., Platzer, R., Blomen, V. A., Xagara, A., Verkerk, T., Bliss, S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.003 · Cited by 105
QSER1 protects DNA methylation valleys from de novo methylation
Dixon, G., Pan, H., Yang, D., Rosen, B. P., Jashari, T., Verma, N., Pulecio, J., Caspi, I., Lee, K., Stransky, S., et al. (2021) · Science · doi:10.1126/science.abd0875 · Cited by 110
Myocardial infarction augments sleep to limit cardiac inflammation and damage
Huynh, P., Hoffmann, J. D., Gerhardt, T., Kiss, M. G., Zuraikat, F. M., Cohen, O., Wolfram, C., Yates, A. G., Leunig, A., Heiser, M., et al. (2024) · Nature · doi:10.1038/s41586-024-08100-w · Cited by 113
Terai, H., Kitajima, S., Potter, D. S., Matsui, Y., Quiceno, L. G., Chen, T., Kim, T. J., Rusan, M., Thai, T. C., Piccioni, F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1904 · Cited by 106
Self-citationLeuzzi, G., Vasciaveo, A., Taglialatela, A., Chen, X., Firestone, T. M., Hickman, A. R., Mao, W., Thakar, T., Vaitsiankova, A., Huang, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.008 · Cited by 113
Tools for experimental and computational analyses of off-target editing by programmable nucleases
Bao, X. R., Pan, Y., Lee, C. M., Davis, T. H., & Bao, G. (2021) · Nature Protocols · doi:10.1038/s41596-020-00431-y · Cited by 106
Molecular definition of the endogenous Toll-like receptor signalling pathways
Fisch, D., Zhang, T., Sun, H., Ma, W., Tan, Y., Gygi, S. P., Higgins, D. E., & Kagan, J. C. (2024) · Nature · doi:10.1038/s41586-024-07614-7 · Cited by 111
Molecular biology at the cutting edge: A review on CRISPR/CAS9 gene editing for undergraduates
Thurtle‐Schmidt, D. M., & Lo, T. (2018) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.21108 · Cited by 103
Canver, M. C., Lessard, S., Pinello, L., Wu, Y., Ilboudo, Y., Stern, E. N., Needleman, A. J., Galactéros, F., Brugnara, C., Kutlar, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3793 · Cited by 105
Douillet, D., Sze, C. C., Ryan, C., Piunti, A., Shah, A. P., Ugarenko, M., Marshall, S. A., Rendleman, E. J., Zha, D., Helmin, K. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0618-1 · Cited by 107
Genome-wide analysis of somatic noncoding mutation patterns in cancer
Dietlein, F., Wang, A. B., Fagre, C. R., Tang, A., Besselink, N. J. M., Cuppen, E. P. J. G., Li, C., Sunyaev, S. R., Neal, J. T., & Allen, E. M. V. (2022) · Science · doi:10.1126/science.abg5601 · Cited by 103
Resources for the design of CRISPR gene editing experiments
Graham, D. B., & Root, D. E. (2015) · Genome biology · doi:10.1186/s13059-015-0823-x · Cited by 108
Self-citationColorimetric Detection of SARS-CoV-2 and Drug-Resistant pH1N1 Using CRISPR/dCas9
Moon, J., Kwon, H.-J., Yong, D., Lee, I.-C., Kim, H., Kang, H., Lim, E., Lee, K., Jung, J., Park, H. G., et al. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01929 · Cited by 104
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Juhász, S., Smith, R., Schauer, T., Spekhardt, D., Mamar, H., Zentout, S., Chapuis, C., Huet, S., & Timinszky, G. (2020) · Science Advances · doi:10.1126/sciadv.abb8626 · Cited by 108
Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin
Wijshake, T., Zou, Z., Chen, B., Zhong, L., Xiao, G., Xie, Y., Doench, J. G., Bennett, L. B., & Levine, B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020478118 · Cited by 104
Self-citationComparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies
Castro, N. G. G., Bjelic, J., Malhotra, G., Huang, C., & Alsaffar, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910355 · Cited by 110
Reductive carboxylation epigenetically instructs T cell differentiation
Jaccard, A., Wyss, T., Maldonado‐Pérez, N., Rath, J. A., Bevilacqua, A., Peng, J.-J., Lepez, A., Gunten, C. V., Franco, F., Kao, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06546-y · Cited by 105
JACKS: joint analysis of CRISPR/Cas9 knockout screensPreprint
Allen, F. R., Behan, F. M., Khodak, A., Iorio, F., Yusa, K., Garnett, M. J., & Parts, L. (2019) · Genome Research · doi:10.1101/gr.238923.118 · Cited by 101
Fujihara, K. M., Zhang, B. Z., Jackson, T. D., Ogunkola, M. O., Nijagal, B., Milne, J. V., Sallman, D. A., Ang, C.-S., Nikolic, I., Kearney, C. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm9427 · Cited by 102
“1 cells expressing Cas9-mCherry with the Brunello genome-wide CRISPR knockout (CRISPRko) library ( 10 ) and challenged these cells with a sublethal dose of epreneta-popt for 8 days (Fig.”
Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a
Creutzburg, S. C. A., Wu, W. Y., Mohanraju, P., Swartjes, T., Alkan, F., Gorodkin, J., Staals, R. H. J., & John van der, O. O. S. T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1240 · Cited by 106
Trembinski, D. J., Bink, D. I., Theodorou, K., Sommer, J., Fischer, A., van Bergen, A. S., Kuo, C., Costa, I. G., Schürmann, C., Leisegang, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15995-2 · Cited by 99
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Xu, Z., Wang, Q., Zhong, H., Jiang, Y., Shi, X., Yuan, B., Yu, N., Zhang, S., Yuan, X., Guo, S., et al. (2022) · Exploration · doi:10.1002/exp.20210081 · Cited by 105
Fang, R., Jiang, Q., Jia, X., & Jiang, Z. (2023) · Immunity · doi:10.1016/j.immuni.2023.02.004 · Cited by 101
BioSeq-Diabolo: Biological sequence similarity analysis using Diabolo
Li, H., & Liu, B. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011214 · Cited by 103
Kausch, A. P., Nelson‐Vasilchik, K., Hague, J. P., Mookkan, M., Quemada, H. D., Dellaporta, S. L., Fragoso, C., & Zhang, Z. J. (2019) · Plant Science · doi:10.1016/j.plantsci.2019.01.006 · Cited by 101
An overview and metanalysis of machine and deep learning-based CRISPR gRNA design tools
Wang, J., Zhang, X., Cheng, L., & Luo, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1669406 · Cited by 106
CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context
Corsi, G. I., Qu, K., Alkan, F., Pan, X., Luo, Y., & Gorodkin, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30515-0 · Cited by 104
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity
Wu, M., Kondo, H., Kammula, A. V., Shi, L., Xiao, Y., Dhiab, S., Xu, Q., Slater, C. J., Avila, O. I., Merritt, J., et al. (2024) · Science · doi:10.1126/science.adl6173 · Cited by 110
Lin, J., Zhang, Z., Zhang, S., Chen, J., & Wong, K. (2020) · Advanced Science · doi:10.1002/advs.201903562 · Cited by 101
Mouridi, S. E., Lecroisey, C., Tardy, P., Mercier, M., Leclercq-Blondel, A., Zariohi, N., & Boulin, T. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.040824 · Cited by 95
Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
Gonçalves, E., Segura‐Cabrera, A., Pacini, C., Picco, G., Behan, F. M., Jaaks, P., Coker, E. A., van der Meer, D., Barthorpe, A. S., Lightfoot, H. W., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199405 · Cited by 106
Bennett, E., Petersen, B. L., Johansen, I. E., Niu, Y., Yang, Z., Chamberlain, C. A., Met, Ö., Wandall, H. H., & Frödin, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa975 · Cited by 108
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
Bhat, A. A., Nisar, S., Mukherjee, S., Saha, N., Yarravarapu, N., Lone, S. N., Masoodi, T., Chauhan, R., Maacha, S., Bagga, P., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03765-1 · Cited by 114
Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics
Rose, J. C., Stephany, J. J., Valente, W. J., Trevillian, B. M., Dang, H. V., Bielas, J. H., Maly, D. J., & Fowler, D. M. (2017) · Nature Methods · doi:10.1038/nmeth.4368 · Cited by 101
A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression
van den Berg, J., Manjón, A. G., Kielbassa-Elkadi, K., Feringa, F. M., Freire, R., & Medema, R. H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky786 · Cited by 101
A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export
van den Boomen, D. J. H., Sienkiewicz, A., Berlin, I., Jongsma, M. L. M., van Elsland, D. M., Luzio, J. P., Neefjes, J., & Lehner, P. J. (2020) · Nature Communications · doi:10.1038/s41467-020-19032-0 · Cited by 98
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 103
Falcomatà, C., Bärthel, S., Widholz, S. A., Schneeweis, C., Montero, J. J., Toska, A., Mir, J., Kaltenbacher, T., Heetmeyer, J., Swietlik, J. J., et al. (2022) · Nature Cancer · doi:10.1038/s43018-021-00326-1 · Cited by 103
Omo‐Lamai, S., Wang, Y., Patel, M. N., Milosavljevic, A., Zuschlag, D. W., Poddar, S., Wu, J., Wang, L., Dong, F., Espy, C. L., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-01974-5 · Cited by 170
Viswanatha, R., Li, Z., Hu, Y., & Perrimon, N. (2018) · eLife · doi:10.7554/elife.36333 · Cited by 79
PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens
Spahn, P. N., Bath, T., Weiss, R. J., Kim, J., Esko, J. D., Lewis, N. E., & Harismendy, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-16193-9 · Cited by 96
Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response
Park, D. E., Cheng, J., Berrios, C. J., Montero, J., Cortés-Cros, M., Ferretti, S., Arora, R., Tillgren, M. L., Gokhale, P. C., & DeCaprio, J. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818798116 · Cited by 104
ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells
Staller, E., Sheppard, C., Neasham, P. J., Mistry, B., Peacock, T. P., Goldhill, D. H., Long, J. S., & Barclay, W. (2019) · Journal of Virology · doi:10.1128/jvi.00217-19 · Cited by 100
Pech, M. F., Fong, L. E., Villalta, J. E., Chan, L. J., Kharbanda, S., O’Brien, J. J., McAllister, F. E., Firestone, A. J., Jan, C. H., & Settleman, J. E. (2019) · eLife · doi:10.7554/elife.47362 · Cited by 98
Krishnan, V., Tallapragada, S., Schaar, B. T., Kamat, K., Chanana, A. M., Zhang, Y., Patel, S. A., Parkash, V., Rinker-Schaeffer, C. W., Folkins, A. K., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01246-z · Cited by 107
Functional single-cell genomics of human cytomegalovirus infection
Hein, M. Y., & Weissman, J. S. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01059-3 · Cited by 97
Base-editing mutagenesis maps alleles to tune human T cell functions
Schmidt, R. L. J., Ward, C. C., Dajani, R., Armour-Garb, Z., Ota, M., Allain, V., Hernandez, R., Layeghi, M., Xing, G., Goudy, L., et al. (2023) · Nature · doi:10.1038/s41586-023-06835-6 · Cited by 101
Murayama, T., Nakayama, J., Jiang, X., Miyata, K., Morris, A. D., Cai, K. Q., Prasad, R. M., Ma, X., Efimov, A., Belani, N., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0486 · Cited by 112
Functional variomics and network perturbation: connecting genotype to phenotype in cancer
Yi, S. S., Lin, S., Li, Y., Zhao, W., Mills, G. B., & Sahni, N. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.8 · Cited by 105
Functional Genomics via CRISPR–Cas
Ford, K. M., McDonald, D., & Mali, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.034 · Cited by 103
Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9
Wu, J., Bell, O. H., Copland, D. A., Young, A., Pooley, J. R., Maswood, R. N., Evans, R. S., Khaw, P. T., Ali, R. R., Dick, A. D., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.012 · Cited by 100
Freimer, J. W., Shaked, O., Naqvi, S., Sinnott-Armstrong, N., Kathiria, A. S., Garrido, C. M., Chen, A. F., Cortez, J. T., Greenleaf, W. J., Pritchard, J. K., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01106-y · Cited by 99
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Ho, P., Melms, J. C., Rogava, M., Frangieh, C. J., Poźniak, J., Shah, S. B., Walsh, Z. H., Kyrysyuk, O., Amin, A. D., Caprio, L., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.014 · Cited by 103
Advances in Integrating Genomics and Bioinformatics in the Plant Breeding Pipeline
Hu, H., Scheben, A., & Edwards, D. (2018) · Agriculture · doi:10.3390/agriculture8060075 · Cited by 97
Kimberland, M. L., Hou, W., Alfonso-Pecchio, A. R., Wilson, S. P., Rao, Y., Zhang, S., & Lu, Q. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.08.007 · Cited by 99
A Chromatin Accessibility Atlas of the Developing Human Telencephalon
Markenscoff-Papadimitriou, E., Whalen, S., Przytycki, P. F., Thomas, R., Binyameen, F., Nowakowski, T. J., Kriegstein, A. R., Sanders, S., State, M. W., Pollard, K. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.002 · Cited by 91
Thymic mimetic cells function beyond self-tolerance
Givony, T., Leshkowitz, D., Castillo, D. D., Nevo, S., Kadouri, N., Dassa, B., Gruper, Y., Khalaila, R., Ben‐Nun, O., Gome, T., et al. (2023) · Nature · doi:10.1038/s41586-023-06512-8 · Cited by 96
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Kang, T. G., Lan, X., Tian, M., Chen, H., Alli, S., Lim, S.-E., Bhatara, S., Vasandan, A. B., Ward, G., Bentivegna, S., et al. (2024) · Science · doi:10.1126/science.adl4492 · Cited by 103
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges
Kalter, N., Fuster‐García, C., Silva, A., Ronco-Díaz, V., Roncelli, S., Turchiano, G., Gorodkin, J., Cathomen, T., Benabdellah, K., Lee, C. M., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102636 · Cited by 121
Optimizing CRISPR/Cas9 for the Diatom Phaeodactylum tricornutum
Stukenberg, D., Zauner, S., Dell’Aquila, G., & Maier, U. G. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00740 · Cited by 100
Zhao, D., Badur, M. G., Luebeck, J., Magaña, J. H., Birmingham, A., Šášik, R., Ahn, C. S., Ideker, T., Metallo, C. M., & Mali, P. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.017 · Cited by 96
Steroid Hormone Function Controls Non-competitive Plasmodium Development in Anopheles
Werling, K., Shaw, W. R., Itoe, M. A., Westervelt, K. A., Marcenac, P., Paton, D. G., Peng, D., Singh, N. P., Smidler, A. L., South, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.036 · Cited by 86
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Law, C., Wacleche, V. S., Cao, Y., Pillai, A., Sowerby, J. M., Hancock, B. L., Horisberger, A., Bracero, S., Skidanova, V., Li, Z., et al. (2024) · Nature · doi:10.1038/s41586-024-07627-2 · Cited by 104
Improved sgRNA design in bacteria via genome-wide activity profiling
Guo, J., Wang, T., Guan, C., Liu, B., Luo, C. Y., Xie, Z., Zhang, C., & Xing, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky572 · Cited by 99
Wertz, M. H., Mitchem, M. R., Pineda, S. S., Hachigian, L. J., Lee, H., Lau, V., Powers, A. E., Kulicke, R., Madan, G. K., Colic, M., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.004 · Cited by 99
Self-citationGenome-scale screens identify factors regulating tumor cell responses to natural killer cells
Sheffer, M., Lowry, E., Beelen, N. A., Borah, M., Amara, S. N.-A., Mader, C. C., Roth, J. A., Tsherniak, A., Freeman, S. S., Dashevsky, O., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00889-w · Cited by 96
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia
Chlon, T. M., Stepanchick, E., Hershberger, C. E., Daniels, N. J., Hueneman, K. M., Davis, A. K., Choi, K., Zheng, Y., Gurnari, C., Haferlach, T., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.08.004 · Cited by 94
DOCK2 is involved in the host genetics and biology of severe COVID-19
Namkoong, H., Edahiro, R., Takano, T., Nishihara, H., Shirai, Y., Sonehara, K., Tanaka, H., Azekawa, S., Mikami, Y., Lee, H., et al. (2022) · Nature · doi:10.1038/s41586-022-05163-5 · Cited by 97
A validated gRNA library for CRISPR/Cas9 targeting of the human glycosyltransferase genome
Narimatsu, Y., Joshi, H. J., Yang, Z., Gomes, C., Chen, Y., Lorenzetti, F. C., Furukawa, S., Schjoldager, K. T.-B. G., Hansen, L. H., Clausen, H., et al. (2017) · Glycobiology · doi:10.1093/glycob/cwx101 · Cited by 93
Yin, K., Han, T., Xie, K., Zhao, J., Song, J., & Liu, Y. (2019) · Phytopathology Research · doi:10.1186/s42483-019-0017-7 · Cited by 93
Pan, M., Wright, W. C., Chapple, R. H., Zubair, A., Sandhu, M., Batchelder, J. E., Huddle, B. C., Low, J. A., Blankenship, K., Wang, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26640-x · Cited by 93
Zhu, H., & Liang, C. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty1061 · Cited by 88
In situ readout of DNA barcodes and single base edits facilitated by in vitro transcription
Askary, A., Sánchez-Guardado, L. Ó., Linton, J. M., Chadly, D. M., Budde, M. W., Cai, L., Lois, C., & Elowitz, M. B. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0299-4 · Cited by 86
Bimbo, J. F., van Diest, E., Murphy, D. E., Ashoti, A., Evers, M. J. W., Narayanavari, S. A., Vaz, D. P., Rijssemus, H., Zotou, C., Saber, N., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011759 · Cited by 107
Iniguez, A. B., Alexe, G., Wang, E. J., Roti, G., Patel, S., Chen, L., Kitara, S., Conway, A. S., Robichaud, A. L., Stolte, B., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.005 · Cited by 92
Xu, S., Zhan, M., Jiang, C., He, M. Y., Yang, L., Shen, H., Huang, S., Huang, X., Lin, R., Shi, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13420-x · Cited by 91
Tóthová, Z., Valton, A.-L., Gorelov, R. A., Vallurupalli, M., Krill-Burger, J. M., Holmes, A. L., Landers, C. C., Haydu, J. E., Małolepsza, E., Hartigan, C. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142149 · Cited by 90
Dubrot, J., Lane-Reticker, S. K., Kessler, E., Ayer, A., Mishra, G., Wolfe, C. H., Zimmer, M. D., Du, P. P., Mahapatra, A., Ockerman, K. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.001 · Cited by 87
Self-citationTumour-wide RNA splicing aberrations generate actionable public neoantigens
Kwok, D. W., Stevers, N. O., Etxeberría, I., Nejo, T., Cove, M. C., Chen, L. H., Jung, J., Okada, K., Lakshmanachetty, S., Gallus, M., et al. (2025) · Nature · doi:10.1038/s41586-024-08552-0 · Cited by 107
Optimization of genome editing through CRISPR-Cas9 engineering
Zhang, J.-H., Adikaram, P. R., Pandey, M., Genis, A., & Simonds, W. F. (2016) · Bioengineered · doi:10.1080/21655979.2016.1189039 · Cited by 94
Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers
Sulahian, R., Kwon, J. J., Walsh, K. H., Pailler, E., Bosse, T. L., Thaker, M., Almanza, D., Dempster, J. M., Pan, J., Piccioni, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.090 · Cited by 90
Self-citationSpatiotemporal allele organization by allele-specific CRISPR live-cell imaging (SNP-CLING)
Maass, P. G., Barutcu, A. R., Shechner, D. M., Weiner, C. L., Melé, M., & Rinn, J. L. (2017) · Nature Structural & Molecular Biology · doi:10.1038/s41594-017-0015-3 · Cited by 90
GUIDES: sgRNA design for loss-of-function screens
Meier, J., Zhang, F., & Sanjana, N. E. (2017) · Nature Methods · doi:10.1038/nmeth.4423 · Cited by 88
CRISPRi-seq for genome-wide fitness quantification in bacteria
de Bakker, V., Liu, X., Bravo, A. M., & Veening, J. (2022) · Nature Protocols · doi:10.1038/s41596-021-00639-6 · Cited by 90
Base editing screens map mutations affecting interferon-γ signaling in cancer
Coelho, M. A., Cooper, S., Strauß, M. E., Karakoç, E., Bhosle, S. G., Gonçalves, E., Picco, G., Burgold, T., Cattaneo, C. M., Veninga, V., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2022.12.009 · Cited by 94
LINE-1 transcription activates long-range gene expression
Li, X., Bie, L., Wang, Y., Hong, Y., Zhou, Z., Fan, Y., Yan, X., Tao, Y., Huang, C., Zhang, Y., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01789-5 · Cited by 97
The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors
Mahameed, M., Wilhelm, T., Darawshi, O., Obiedat, A., Weiss‐Sadan, T., Chintha, C., Schubert, T. E. O., Afshin Samali, A., Chevet, É., Eriksson, L. A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1523-3 · Cited by 89
Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency
Hiranniramol, K., Chen, Y., Liu, W., & Wang, X. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa041 · Cited by 93
Bell, S. L., Lopez, K. L., Cox, J. S., Patrick, K. L., & Watson, R. O. (2021) · mBio · doi:10.1128/mbio.01871-20 · Cited by 92
Metadata
- Authors
- Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., Virgin, H. W., Listgarten, J., & Root, D. E.
- Affiliations
- Broad Institute (US)
- Washington University in St. Louis (US)
- Microsoft Research New England (United States) (US)
- Corresponding author
- Doench, John G
- Listgarten, Jennifer
- Root, David E
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2016-01-18
- Volume
- 34
- Issue
- 2
- Pages
- 184-191
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC4744125
- OpenAlex
- W2252568502
- Semantic Scholar
- b9e5fa707e804d6008e5011b058244437c656a93
- Cited by
- 4,637
- References
- 54
- Citations by year
- 2026: 494 · 2025: 658 · 2024: 569 · 2023: 572 · 2022: 538 · 2021: 499 · 2020: 463 · 2019: 337 · 2018: 258 · 2017: 170 · 2016: 75
- FWCI
- 144.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (K12CA087723)
- National Institute of Allergy and Infectious Diseases (U19AI109725, T32AI007163)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- sgRNA design, CRISPR/Cas9, off-target effects, on-target activity, genetic screen, off-target prediction, genome editing, human genome, mouse genome
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Animals, Drug Resistance, Genetic Engineering, Humans, Gene Library, Genome, Genomics, Cell Line, Tumor, Mice, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
